The symposium will use case-based discussions, promote the understanding of recent technologies for the treatment of mitral tricuspid or aortic valve works.
The program will highlight patients’ characteristics that qualify them to benefit from these technologies.
Registration:
www.texasheart.org/palacios23
Commentaires